The core problem the researchers set out to solve is one that has dogged the genome-editing field for years. When Cas9 is introduced into a fertilized egg at the single-cell stage, as is routine in zebrafish studies, the enzyme may continue to cut DNA after the embryo begins to divide. Each subsequent cut-and-repair event creates a genetically distinct cell lineage, so the animal that develops is not a uniform carrier of one intended edit but a patchwork of different alleles distributed across its tissues. This phenomenon, known as mosaicism, is well recognized, yet characterizing it thoroughly has been difficult, particularly when the events involved are structural variants occurring at low frequency. Short-read sequencing struggles to resolve large insertions, deletions, and rearrangements, and amplification-based methods can distort the true proportions of variant molecules in a sample.

To overcome these limitations, the team turned to amplification-free targeted sequencing on the PacBio platform using the PureTarget approach, which enriches predefined genomic regions without polymerase chain reaction. Thirty samples from pooled zebrafish larvae and individual adult fish were sequenced successfully, yielding an average coverage of more than 1,100-fold across the target loci. Critically, the reads achieved a consensus accuracy of QV39, meaning fewer than one error per billion bases, which the authors describe as near-perfect. Every read originated from a unique DNA molecule, so the depth of coverage translated directly into an unbiased census of the alleles present. The two haplotypes of each target locus showed balanced depth of coverage, a sign that the method captures both maternal and paternal chromosomes without preference.

The contrast with conventional approaches was striking. When the researchers applied long-range PCR to the same samples before sequencing, the resulting data were skewed, with certain alleles overrepresented and others underrepresented relative to the amplification-free measurements. This matters because many laboratories still rely on PCR-based amplicon sequencing to verify their editing experiments, and the new results indicate that such workflows can systematically misrepresent the complexity of what is actually present in an edited animal. By removing the amplification step entirely and reading native DNA molecules directly, PureTarget preserves the true variant allele frequencies, allowing even rare structural variants to be detected and quantified with confidence.

The biological findings were equally significant. Analysis of individual founder fish, the F0 animals injected at the single-cell embryo stage, revealed extensive mosaicism. A single adult founder carried up to 18 distinct on-target editing events at the intended locus, and up to 11 different off-target events elsewhere in the genome. In other words, one fish that might superficially appear to carry a simple knockout mutation was in fact a living mosaic of dozens of different indels, deletions, inversions, and other rearrangements, each present in a different fraction of its cells. Many of these events would be invisible to standard genotyping PCR or short-read sequencing, which typically only confirms the presence or absence of the intended edit.

Perhaps the most consequential discovery concerned inheritance. When the founders were bred, several editing outcomes, including large structural variants and off-target mutations, were transmitted to the F1 generation. Among juvenile siblings derived from a single founder pair, the researchers identified as many as seven unique editing events. This confirms that mosaicism was present not only in the somatic tissues of the founders but also in their germ cells, meaning that different gametes carried different edited alleles. The practical implication is profound: some consequences of CRISPR-Cas9 editing may only become apparent in the second generation, so a founder that screens negative for off-target mutations in a blood or fin biopsy could still be silently transmitting unexpected variants to its offspring.

For the zebrafish community, which generates thousands of edited lines each year for studies of development, disease modeling, and gene function, these findings argue for more rigorous genotyping strategies. A line established from a mosaic founder may harbor multiple distinct alleles that segregate in subsequent generations, confounding phenotypic interpretation if researchers assume all carriers share an identical mutation. Structural variants that remove or invert large genomic segments can affect neighboring genes, and off-target mutations that hitchhike through the germline could introduce unrelated phenotypes. The study suggests that careful outcrossing and thorough molecular characterization of early generations remain essential, and that the depth and accuracy of the method used for that characterization determine what can actually be seen.

Beyond counting mutations, the platform also allowed the team to interrogate epigenetic signals embedded in the same sequencing data. PacBio reads carry kinetic information that can be used to infer DNA methylation, and the researchers analyzed 5-methylcytosine levels at CpG dinucleotides across the targeted regions in their edited samples. Notably, they did not observe altered 5mC CpG levels in the genome-edited fish compared with controls, providing some reassurance that Cas9 cutting at these loci did not perturb local methylation patterns. This ability to profile both genetic mosaicism and DNA methylation from a single amplification-free dataset illustrates the versatility of the approach for pre-defined genomic regions of interest.

The technical achievement rests on a combination of factors: amplification-free library preparation that avoids PCR-induced bias, targeted enrichment that concentrates sequencing capacity on the loci that matter, and the high intrinsic accuracy of PacBio HiFi reads, here pushed to exceptional consensus quality over the target regions. The authors note that the work was supported by a technology development project grant from SciLifeLab’s National Genomics Infrastructure, with library preparation performed in Uppsala and sequencing carried out at Clinical Genomics Uppsala. Some reagents were provided by PacBio, and one author received conference travel support from the company, disclosures that are stated in the paper. All zebrafish experiments were approved by the Uppsala University Ethical Committee for Animal Research.

The broader message for the genome-editing field is that the true complexity of CRISPR outcomes has likely been underestimated, not because the events are rare but because the tools used to detect them were not up to the task. As CRISPR-based therapies advance through clinical trials and edited animal models underpin countless studies, the ability to comprehensively profile mosaicism, structural variation, and off-target effects with single-molecule accuracy becomes a matter of scientific validity and safety. This study demonstrates that near-perfect long-read sequencing of targeted regions can provide that visibility, and it warns that what happens in the cutting bowl does not stay in the founder: some of CRISPR’s unintended edits can echo quietly into the next generation before anyone notices.

Subject of Research: Characterization of CRISPR-Cas9 editing outcomes and genetic mosaicism using near-perfect targeted long-read sequencing in zebrafish

Article Title: Accurate characterization of CRISPR-Cas9 genome editing outcomes and mosaicism with near-perfect long reads

Article References: Höijer, I., van Schendel, R., Emmanouilidou, A., Östlund, R., Bunikis, I., Tijsterman, M., den Hoed, M., & Ameur, A. (2026). Accurate characterization of CRISPR-Cas9 genome editing outcomes and mosaicism with near-perfect long reads. Genome Medicine, 18(1), Article 135. https://doi.org/10.1186/s13073-026-01772-1

Image Credits: AI Generated

DOI: 10.1186/s13073-026-01772-1

Keywords: CRISPR-Cas9, genome editing, genetic mosaicism, off-target mutations, structural variation, long-read sequencing, PacBio, PureTarget, zebrafish, DNA methylation, targeted sequencing, Genome Medicine

The researchers, led by Caoimhe Morley and Christos Proukakis, built on their earlier finding that somatic copy number gains of SNCA, the gene encoding alpha-synuclein, occur in the brains of people with synucleinopathies. In their new study, published in Acta Neuropathologica, they asked whether these gains arise specifically in oligodendrocytes, whether they cluster in the brain regions most damaged by the disease, and whether they correlate with the pathological inclusions that define it. Their strategy hinged on a technically demanding hybrid method that combines fluorescent in situ hybridisation, or FISH, with immunofluorescence, applied not to tissue sections but to suspensions of individual nuclei isolated from fresh-frozen post-mortem brain tissue.

The methodological choice matters. Working on sections makes it nearly impossible to reliably detect copy number losses, because slicing the tissue can truncate FISH signals and mimic a missing gene copy. Isolating nuclei eliminates this artefact while preserving alpha-synuclein inclusions, which in multiple system atrophy often sit in perinuclear or nuclear positions and remain attached to the nuclei during preparation. Each nucleus could therefore be interrogated on several axes simultaneously: the number of SNCA copies it carried, whether it belonged to the oligodendrocyte lineage as marked by the transcription factor SOX10, and whether it harboured an alpha-synuclein inclusion. The team analysed tissue from the putamen, cerebellum and substantia nigra of 13 cases with the striatonigral degeneration subtype, 12 cases with the olivopontocerebellar atrophy subtype, and 15 controls from the Queen Square Brain Bank.

The results were striking. Somatic SNCA copy number variants, both gains and losses, were significantly more frequent in multiple system atrophy oligodendrocytes than in controls. Gains were enriched more than threefold, appearing in 6.3 percent of SOX10-positive oligodendrocytes compared with 2.0 percent in controls, while losses were present in 12.5 percent versus 7.4 percent, with both differences highly significant. Crucially, the gains were not randomly distributed. They concentrated in the regions preferentially devastated by each disease subtype: the putamen in striatonigral degeneration and the cerebellum in olivopontocerebellar atrophy, along with the substantia nigra in both. The analysis also showed that CNVs were preferentially enriched at the SNCA locus itself; a chromosome 7 reference probe displayed relative genomic stability, indicating a locus-specific phenomenon rather than wholesale genomic chaos.

The single-cell correlations provide the study’s most provocative evidence. In the preferentially affected region of each subtype, oligodendrocytes carrying a somatic SNCA gain were more than twice as likely to contain an alpha-synuclein inclusion as their neighbours with a normal copy number, an effect that vanished in less affected regions. At the regional level, the frequency of oligodendrocyte gains correlated significantly with the overall burden of glial inclusions. This dovetails with established biology: people who inherit extra copies of SNCA develop parkinsonism driven by chronic alpha-synuclein overproduction, with duplications causing later-onset disease and triplications causing aggressive early-onset forms. Mouse models engineered to overexpress human alpha-synuclein specifically in oligodendrocytes develop inclusion-like pathology, demyelination and neuroinflammation. The new data suggest that the same dosage logic operates cell by cell in the human disease brain, with gains locally pushing intracellular alpha-synuclein toward the aggregation threshold.

Perhaps the most clinically resonant finding is a correlation between copy number gain burden and disease onset. Cases carrying a higher average proportion of oligodendrocyte SNCA gains developed symptoms significantly earlier, with a Spearman correlation coefficient of minus 0.45 and a p-value of 0.03. No such relationship existed for gains in non-oligodendroglial cells or for losses. Moreover, within individual cases, the level of gains correlated across brain regions and between oligodendrocytes and other cell populations, hinting that some patients carry an intrinsic, case-wide propensity for SNCA mosaicism. This raises the possibility of an early clonal event, arising during development, that seeds descendant cells across multiple regions and predisposes the brain to alpha-synuclein aggregation decades later. Distinguishing this from a generalised susceptibility to SNCA instability will require deep single-cell whole-genome sequencing, which is only now approaching the necessary resolution.

The study also reported, for the first time in multiple system atrophy, somatic SNCA losses. These were elevated in both oligodendrocytes and other cells but told a different story. They showed no clear regional predilection matching each subtype’s pathology, associated with inclusions only in the substantia nigra, and showed no correlation with age of onset or disease duration. That pattern argues against a primary causal role. Unlike gains, germline losses of SNCA have never been linked to synucleinopathies, and mice lacking alpha-synuclein do not develop relevant neurodegenerative phenotypes. The authors instead propose that losses may arise secondarily as the disease progresses, through the mis-repair of DNA damage.

That hypothesis gains weight from the study’s final arm, an examination of DNA double-strand breaks using immunofluorescence for gamma H2AX, the phosphorylated histone that marks sites of breakage and repair. Across the sampled regions, the proportion of gamma H2AX-positive cells was significantly higher in multiple system atrophy than in controls, 4.9 versus 2.5 percent overall, and nearly fourfold higher within oligodendrocytes. The signal was stronger in the preferentially affected regions and, strikingly, present in 22.2 percent of inclusion-bearing cells versus 14.9 percent of inclusion-free ones. This mirrors recent reports in Lewy body diseases linking DNA damage to alpha-synuclein pathology. Because post-mitotic brain cells repair double-strand breaks through the error-prone non-homologous end joining pathway, unrepaired or mis-repaired breaks can generate deletions, potentially including SNCA itself. Yet the authors caution that more than three-quarters of inclusion-positive cells showed no evidence of breaks, and the temporal sequence of damage, aggregation and copy number change remains unresolved.

The findings do not paint copy number variation as a sole cause. Most inclusion-bearing oligodendrocytes carried a normal SNCA copy number, and individuals with inherited SNCA multiplications typically develop a Parkinson-like picture rather than full multiple system atrophy, suggesting that somatic gains act as one influential contributor among many, a first hit or modifier that lowers the threshold for aggregation within vulnerable glia. Cell-type-specific stress, environmental exposures, unidentified inherited variants and other somatic mutations, possibly including age-related clonal haematopoiesis recently associated with the disease, are likely to complete the picture. Even so, the work reframes the search for multiple system atrophy’s origins. The culprit may not lie in the genome everyone inherits, but in the mosaic of genomes that individual brain cells acquire across a lifetime, and in oligodendrocytes silently accumulating extra copies of the very gene whose protein will one day fill them with inclusions.

Subject of Research: Somatic SNCA copy number variation in oligodendrocytes and its role in multiple system atrophy pathogenesis

Article Title: Oligodendroglial somatic SNCA copy number gains are associated with inclusions and disease onset in multiple system atrophy

Article References: Oligodendroglial somatic SNCA copy number gains are associated with inclusions and disease onset in multiple system atrophy. (n.d.). https://doi.org/10.1007/s00401-026-03077-4

Image Credits: AI Generated

DOI: 10.1007/s00401-026-03077-4

Keywords: multiple system atrophy, SNCA, alpha-synuclein, oligodendrocytes, somatic copy number variants, glial cytoplasmic inclusions, DNA double-strand breaks, gamma H2AX, fluorescent in situ hybridisation, genetic mosaicism, synucleinopathy, neurodegeneration